Name: Latest research reports of Abbott India Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Abbott India Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Expensive Performer

26955.0000 95.00 (0.35%)

NSE Sep 25, 2026 15:31 PM

52W Low on Sep 11, 2026

Volume: 2,263

Abbott India Ltd.

03 Sep 2026

26955.00

0.35%

Abbott India (BUY): Most brands in core portfolio growing healthilyAbbott India's core portfolio sales grew on both a sequential and yearly basis as of 1QFY27View Report

Buy: Abbott India Ltd.

Target

BOB Capital Markets Ltd.

Abbott India's core portfolio sales grew on both a sequential and yearly basis as of 1QFY27

Abbott India Ltd. is trading above its 200 day SMA of 26921.4